KENNETH SPENCER: Open Payments
NPI 1356869549 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 52 payments from 15 companies in 2025. Trend: 2023 $1,094 · 2024 $1,068 · 2025 $1,285
Food & beverage: $1,047Education: $238
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $262 |
| ABBVIE INC. | 12 | $230 |
| GENZYME CORPORATION | 6 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Lilly USA, LLC | 5 | $97 |
| PFIZER INC. | 1 | $94 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 1 | $72 |
| UCB, Inc. | 3 | $54 |
| Incyte Corporation | 1 | $35 |
Products named: DUPIXENT, SKYRIZI, ILUMYA, TALTZ, LITFULO, COSENTYX, Bimzelx, RINVOQ.
Industry payments across TX — which companies pay providers there.
